Atlanta, GA, United States of America

Shreenivas R Lingireddy

This inventor holds 2 USPTO granted patents. Top assignee: Amplio Pharma, LLC. Active years: 2017-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shreenivas R Lingireddy. Retrieved from https://idiyas.com/inventor/shreenivas-r-lingireddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2017-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Shreenivas R Lingireddy

Introduction

Shreenivas R Lingireddy is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on crystalline forms of specific compounds. With a total of 2 patents, his inventions are paving the way for advancements in therapeutic applications.

Latest Patents

Lingireddy's latest patents focus on novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione. These include a variety of cocrystals, such as a urea cocrystal, a gallic acid cocrystal, a propyl gallate cocrystal, and an L-tartaric acid cocrystal. The preparation and characterization of these crystalline forms are described in detail, along with their potential pharmaceutical compositions and therapeutic uses.

Career Highlights

Lingireddy is currently associated with Amplio Pharma, LLC, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to enhancing the efficacy and safety of therapeutic compounds.

Collaborations

Some of his notable coworkers include Scott Lawrence Childs and Nathan Barishansky, who contribute to the collaborative environment at Amplio Pharma, LLC.

Conclusion

Shreenivas R Lingireddy's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to advancing medical science. His work continues to inspire and pave the way for future developments in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…